MADISON, Wis.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Financing?src=hash" target="_blank"gt;#Financinglt;/agt;--Imbed Biosciences closes $2M in Series A financing to commercialize next-generation FDA-cleared wound healing matrix. : MADISON, Wis.--(BUSINESS WIRE)--Imbed Biosciences Inc. (Imbed), a medical device company emerging as a leader in the development of advanced therapies for soft tissue repair, announced today that it has closed $2 million in a Series A Preferred Stock equity financing.